Physician profile
Gregory A Szych
NPI 1841268521
$2,433.46
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,776 · 2020: $13.23 · 2021: $300 · 2022: $163 · 2023: $112 · 2024: $69.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,378.10 | 2019-2024 | Resolution 360 Clip |
| Covidien LP | $377.93 | 2019 | |
| Nestle Healthcare Nutrition INC. | $178.38 | 2021-2022 | |
| Abbvie INC. | $128.62 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $111.85 | 2023 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $101.61 | 2022 | |
| Cook Medical LLC | $28.57 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.83 | 2024 | Entyvio |
| Redhill Biopharma INC. | $18.44 | 2021 | |
| Pfizer INC. | $16.74 | 2019 | |
| Intercept Pharmaceuticals, INC. | $16.58 | 2019 | |
| Celgene Corporation | $16.16 | 2021 | |
| Janssen Biotech, INC. | $15.18 | 2024 | Stelara |
| Braintree Laboratories, INC. | $14.64 | 2024 | Suflave |
| Merck Sharp & Dohme LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Szych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.